Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-09-16

Clinical Trial Update: The Influence of Metformin on Chronic Heart Failure Clinical Course in Patients With Prediabetes [Phase 4]

View source ↗

Summary

Phase 4 trial assessing the influence of metformin on the clinical course of chronic heart failure in patients with prediabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • metformin (metformin)

Snippet

Sponsor: National Center of Cardiology and Internal Medicine named after academician M.Mirrakhimov | Conditions: Chronic Heart Failure, Coronary Artery Disease | Phase 4 | Status: COMPLETED